Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.

The growth fractions of 160 mammary carcinomas and 30 benign mammary lesions were determined in situ by immunostaining with the monoclonal antibody Ki-67. Benign lesions had a mean value of 3% Ki-67 positive cells, whereas the mean value of mammary carcinomas was 16.6%. A comparison of the mean valu...

Descripción completa

Detalles Bibliográficos

Publicado en:	J Clin Pathol
Autores principales:	Gerdes, J, Lelle, R J, Pickartz, H, Heidenreich, W, Schwarting, R, Kurtsiefer, L, Stauch, G, Stein, H
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMJ Publishing Group 1986
Materias:	Research Article
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC500196/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3020096/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jcp.39.9.977
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!